|
|
On
September 30, 2004, the international prescription
drug company Merck announced the worldwide withdrawal
of the arthritis medication Rofecoxib, sold
in most countries under the brand name Vioxx,
because a study showed an increased risk of
heart attack and stroke. Patients who have suffered
injuries due to Vioxx have filed litigation
against Merck for failing to recall the drug
when it first learned of Vioxx's dangerous side
effects.
To contact in confidence an experienced personal
injury attorney at Lieff Cabraser working on
the Vioxx lawsuit, click
here. |
|
|
|
|
|
The
painkiller Vioxx was marketed throughout the
world, sold in many countries under the name
Vioxx and in others as Ceoxx. Lieff Cabraser
is working with attorneys and solicitors in:
Argentina
 Austria
Canada
Ireland
Italy
South Africa
United
Kingdom
and other countries to bring litigation against
Merck in U.S. courts for patients suffering
heart attacks and strokes from Vioxx. If you
are visiting this website from outside the U.S.,
please click here
to contact an attorney regarding your experiences
with Vioxx or Ceoxx. |
|
|
|
| |
|
Vioxx Attorney | Vioxx Lawyer Profiles
|
|
| Lieff
Cabraser Heimann & Bernstein, LLP is a national law
firm of over sixty attorneys with offices located in San
Francisco, New York, Washington, D.C., Beverly Hills and
Nashville. In 2003 and 2004, the National Law Journal
recognized Lieff Cabraser as one of the top 20 plaintiffs’
law firms in America. |
| The
following is a partial list of our attorneys working on
personal injury lawsuits, including Vioxx. To
communicate with an experienced personal injury lawyer
directly and promptly for no charge and with no obligation,
click here. |
| For
our personal injury cases, we bring a team of experienced
lawyers. Each client is assigned a partner and an associate.
In addition, we have on staff multiple nurses, legal assistants,
scientific analysts and case clerks to assist the attorneys.
To learn more about our firm, click
here. |
|
|
 Elizabeth
J. Cabraser
Partner
Click
here for full profile |
Richard
M. Heimann
Partner
Click
here for full profile |
|
|
 Donald
C. Arbitblit
Partner
Click
here for full profile |
Steven
E. Fineman
Partner
Click
here for full profile |
|
|
Fabrice
N. Vincent
Partner
Click
here for full profile |
Wendy
R. Fleishman
Partner
Click
here for full profile |
|
|
Heather
A. Foster
Partner
Click
here for full profile |
Paulina
do Amaral
Partner
Click
here for full profile |
|
|
Steven
M. Tindall
Partner
Click
here for full profile |
Kathryn
E. Barnett
Partner
Click
here for full profile |
|
|
Joy
A. Kruse
Partner
Click
here for full profile |
Karin
Kramer
Of Counsel
Click
here for full profile |
|
|
Susie
Injijian
Of Counsel
Click
here for full profile |
Daniel
E. Barenbaum
Associate
Click
here for full profile |
|
|
Mark
P. Chalos
Associate
Click
here for full profile |
Daniel
P. Chiplock
Associate
Click
here for full profile |
|
|
Matthew
S. Da Vega
Associate
Click
here for full profile |
Jennifer
Gross
Associate
Click
here for full profile |
|
|
Rebecca
Poate
Associate
Click
here for full profile |
Daniel
H. Rose
Associate
Click
here for full profile |
|
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
Copyright
© 2004-2005 Lieff Cabraser Heimann & Bernstein,
LLP
|
| |
|
|
"Researcher
says 139,000 harmed by Vioxx," Reuters,
Jan. 3, 2005
Just weeks after Forbes announced Merck's
Vioxx liability could reach US$38 billion,
the U.S. drug safety officer who warned months
ago about risks from Merck & Co. Inc.’s
painkiller Vioxx has won clearance to publish
a study arguing the now-recalled drug may have
caused up to 139,000 excess cases of heart attacks
and strokes. More...
To read more press articles on the Vioxx recall
and Vioxx class action lawsuit, click
here. |
|
|
|
|
|
| Lieff
Cabraser has participated in twenty-three $100
million-plus settlements and verdicts. To read
a summary, click here. |
|
|
|
|
|
Click here to read
recent press articles on the Vioxx recall and
Vioxx lawsuits. |
|
|
|
|
|
Read about key events in the Vioxx recall and
Vioxx lawsuit by clicking
here. |
|
|
|
|